Microfluidic Liver-on-a-Chip for Preclinical Drug Discovery

Abstract

Drug discovery is an expensive, long, and complex process, usually with a high degree of uncertainty. In order to improve the efficiency of drug development, effective methods are demanded to screen lead molecules and eliminate toxic compounds in the preclinical pipeline. Drug metabolism is crucial in determining the efficacy and potential side effects, mainly in the liver. Recently, the liver-on-a-chip (LoC) platform based on microfluidic technology has attracted widespread attention. LoC systems can be applied to predict drug metabolism and hepatotoxicity or to investigate PK/PD (pharmacokinetics/pharmacodynamics) performance when combined with other artificial organ-on-chips. This review discusses the liver physiological microenvironment simulated by LoC, especially the cell compositions and roles. We summarize the current methods of constructing LoC and the pharmacological and toxicological application of LoC in preclinical research. In conclusion, we also discussed the limitations of LoC in drug discovery and proposed a direction for improvement, which may provide an agenda for further research.

Microfluidic Devices: A Tool for Nanoparticle Synthesis and Performance Evaluation

“…These devices provide a more representative physiological environment compared to 2D assays, enabling us to study a particular phenomenon in models that closely resemble those found in living organisms. Indeed, they offer a valuable alternative for studying, e.g., cellular behavior, drug responses in disease models, providing meaningful insights, and generate more straightforward and conclusive human-related data that contribute to reducing the number of animals used in research. − Microfluidic-based cell cultures present numerous advantages, such as allowing a dynamic and controlled environment (e.g., chemical gradients, flow rate, shear stress, pH, CO 2 , O 2 , or temperature), the continuous inflow of nutrients by perfusion, regular waste removal, less consumption of fluids, automated liquid handling systems (e.g., pumps), and the possibility of integration with biosensors . Therefore, microfluidic systems are increasingly being used as resourceful tools and valuable alternatives to traditional approaches.…”

Evaluating the antioxidant potential of resveratrol-gold nanoparticles in preventing oxidative stress in endothelium on a chip

“…They can demonstrate the effects of different substances, drugs, and mechanisms 20 . These simulated platforms, by better simulating physiological conditions and better drug efficiency prediction using sophisticated in vitro models, have bridged the gap between data from animal and human studies 21 – 23 . MFC devices provide distinct advantages over conventional in vitro cell culture methods, by better regulating the micro environmental factors, such as fluid flow, shear stress, and gradients of nutrients and oxygen, that significantly impact the cellular behavior and the results of drug screening experiments 24 , 25 .…”